Physician profile
Samir Rahman
NPI 1275020463
$9,387.31
in general payments reported to CMS, 2019-2025
8 companies · $4,414 in 2025
The $4,414 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $4,698 · 2024: $276 · 2025: $4,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,160 · Education: $2,750 · Travel and Lodging: $1,591 · Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,160.00 |
| Education | $2,750.00 |
| Travel and Lodging | $1,590.69 |
| Food and Beverage | $886.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $5,455.47 | 2023-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $3,682.34 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Tela Bio, INC. | $163.13 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $23.03 | 2025 | Dermabond |
| Myriad Genetic Laboratories, INC. | $21.08 | 2023 | Myrisk |
| Mimedx Group, INC. | $14.37 | 2024 | |
| Mozarc Medical US LLC | $14.32 | 2025 | Palindrome |
| Solventum Corporation | $13.57 | 2025 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.